جمعه 1 اسفند 1404
[Archive]
دوره 33، شماره 162 - ( Special Issue 1404 )
جلد 33 شماره 162 صفحات 2-2 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Al-Musawi A J, Mashaf A A, Amran M. Synthesis and Pharmacological Activities of Naproxen Derivatives – A review. J Adv Med Biomed Res 2025; 33 (162) :2-2
URL: http://journal.zums.ac.ir/article-1-7895-fa.html
URL: http://journal.zums.ac.ir/article-1-7895-fa.html
Synthesis and Pharmacological Activities of Naproxen Derivatives – A review. Journal of Advances in Medical and Biomedical Research. 1404; 33 (162) :2-2
چکیده: (162 مشاهده)
Naproxen is a medication classified as a non-steroidal anti-inflammatory medicine (NSAID) utilized for its anti-inflammatory properties. The principal functional group in naproxen is the carboxyl group, prompting numerous researchers to modify this group to synthesize novel derivatives of naproxen and investigate their pharmacological efficacy, with the aim of discovering more effective molecules than naproxen. This review examines the methodologies for synthesizing derivatives, emphasizing notable molecules with unique biological activity and the key techniques employed in these investigations. Modification of naproxen to include triazole 5n has been found to enhance the efficacy of the derivative and constitute a potential treatment for prostate cancer. The presence of pyrazole and pyrazoline derivatives 9c and 12f enhances the anti-inflammatory and anti-proliferative activity of the derivative. Research has also found that modifying the carboxyl group of naproxen to derivatives containing heterogeneous sulfur rings, such as thiazole and thiadiazole 14a and 22q, whether as single or fused rings, enhances its anti-inflammatory and analgesic activity. Amines and amino acids 26a, 26b, 29b, 32b, and 33b have also been observed to enhance its anti-inflammatory and analgesic activity. These compounds exhibited high oral absorption and were not carcinogenic or toxic in rodent studies, showing safety and minimal ulceration. The most prominent derivatives that inhibit the COX-2 enzyme are hydrazone derivatives that contain the functional group (-NH-N=CH-), and the substituted m-chlorophenyl 35c emerged as the most inhibitory derivative.
نوع مطالعه: مقاله مروری |
موضوع مقاله:
Pharmacology
دریافت: 1404/7/18 | پذیرش: 1404/8/26 | انتشار: 1404/10/8
دریافت: 1404/7/18 | پذیرش: 1404/8/26 | انتشار: 1404/10/8
فهرست منابع
1. Brutzkus JC, Shahrokhi M, Varacallo MA. Naproxen. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: [https://www.ncbi.nlm.nih.gov/books/NBK525965/]
2. Deb J, Majumder J, Bhattacharyya S, Jana SS. A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells. BMC Cancer. 2014;14(1):567. [DOI:10.1186/1471-2407-14-567] [PMID] [PMCID]
3. Hanson P, Maddison J. Nonsteroidal anti-inflammatory drugs and chondroprotective agents. In:Small Animal Clinical Pharmacology. 2nd Edition. 2008;5:287. [DOI:10.1016/B978-070202858-8.50015-4]
4. Lee AV, Oesterreich S, Davidson NE. MCF-7 cells-changing the course of breast cancer research and care for 45 years. J Natl Cancer Inst. 2015;107(7):djv073. [DOI:10.1093/jnci/djv073] [PMID]
5. Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: [https://www.ncbi.nlm.nih.gov/books/NBK547742/]
6. Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11(2):81s-110s. [DOI:10.18433/J3T886] [PMID]
7. Panchal NK, Prince Sabina E. Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities. Food Chem Toxicol. 2023;172:113598. [DOI:10.1016/j.fct.2022.113598] [PMID]
8. Dilekoglu MF, Yapici M. Adsorption of naproxen pharmaceutical micropollutant from aqueous solutions on superior activated carbon synthesized from sheep manure: kinetics, thermodynamics, and mechanism. J Mol Liq. 2023;381:121839. [DOI:10.1016/j.molliq.2023.121839]
9. Khalil NA, Ahmed EM, Tharwat T, Mahmoud Z. NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead. RSC Adv. 2024;14(42):30647-61. [DOI:10.1039/D4RA04686B] [PMID] [PMCID]
10. Terzi M, Altun G, Şen S, Kocaman A, Kaplan AA, Yurt KK, et al. The use of non-steroidal anti-inflammatory drugs in neurological diseases. J Chem Neuroanat. 2018;87:12-24. [DOI:10.1016/j.jchemneu.2017.03.003] [PMID]
11. Feigenson KA, Kusnecov AW, Silverstein SM. Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev. 2014;38:72-93. [DOI:10.1016/j.neubiorev.2013.11.006] [PMID] [PMCID]
12. Flecknell P. Analgesia and Post-Operative Care. Laboratory animal anaesthesia. 4th ed: Academic press; 2009. [DOI:10.1016/B978-0-12-369376-1.00005-8]
13. Pang X, Li H, Chen L. Triazoles: a privileged scaffold in drug design and novel drug discovery. Privileged Scaffolds in Drug Discovery2023. p. 105-15. [DOI:10.1016/B978-0-443-18611-0.00030-9]
14. Birgül K, Yıldırım Y, Karasulu HY, Karasulu E, Uba AI, Yelekçi K, et al. Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives. Eur J Med Chem. 2020;208:112841. [DOI:10.1016/j.ejmech.2020.112841] [PMID]
15. Niu ZX, Wang YT, Zhang SN, Li Y, Chen XB, Wang SQ, et al. Application and synthesis of thiazole ring in clinically approved drugs. Eur J Med Chem. 2023;250:115172. [DOI:10.1016/j.ejmech.2023.115172] [PMID]
16. Seyfimoghaddam M, Foroughifar N, Pasdar H, Khajeh-Amiri A. Using of Naproxen drug for novel synthesis of 4-thiazolidinone derivatives and application of these drugs as no steroidal anti-inflammatory drug (NSAIDs) and as anti-epileptic agent. Int J Adv Sci Res. 2018;5(2):237380. [DOI:10.22161/ijaers.5.2.9]
17. Ostrovskii VA, Koldobskii GI, Trifonov RE. Tetrazoles. Comprehensive Heterocyclic Chemistry III. 2008, Vol. 6, pp. 257-423 Amsterdam, Netherlands: Elsevier. [DOI:10.1016/b978-008044992-0.00517-4]
18. Mahmood WAR. Preparation and Characterization some New of Naproxen Drug Derivatives. Baghdad Sci J. 2017;14(3):564-74. [DOI:10.21123/bsj.14.3.564-574] [DOI:10.21123/bsj.2017.14.3.0564]
19. Singh G, Chandra P, Sachan N. Chemistry and pharmacological activities of pyrazole and pyrazole derivatives: a review. Int J Pharm Sci Rev Res. 2020;65(1):201-14. [DOI:10.47583/ijpsrr.2020.v65i01.030]
20. Küçükgüzel Ş G, Şenkardeş S. Recent advances in bioactive pyrazoles. Eur J Med Chem. 2015;97:786-815. [DOI:10.1016/j.ejmech.2014.11.059] [DOI:10.1016/j.ejmech.2014.11.033]
21. Al-Sehemi AG, Irfan A, Alfaifi M, Fouda AM, El-Gogary TMm, Ibrahim DA. Computational study and in vitro evaluation of the anti-proliferative activity of novel naproxen derivatives. J King Saud Univ Sci. 2017;29(3):311-9. [DOI:10.1016/j.jksus.2017.01.003]
22. Ravindar L, Hasbullah SA, Rakesh KP, Hassan NI. Pyrazole and pyrazoline derivatives as antimalarial agents: A key review. Eur J Pharm Sci. 2023;183:106365. [DOI:10.1016/j.ejps.2022.106365] [PMID]
23. Mahdi MF, Raauf AMR, Mohammed NM. Synthesis, characterization and preliminary pharmacological evaluation of new non-steroidal anti-inflammatory pyrazoline derivatives. Eur J Chem. 2015;6(4):461-7. [DOI:10.5155/eurjchem.6.4.461-467.1321]
24. Atiya RN. Preparations, Reactions and Biological Activities of 1, 3, 4-Thiadiazole Derivatives: Reviewing Study. J Kufa Chem Sci. 2020;2(6):87-101.
25. Grover G, Nath R, Bhatia R, Akhtar MJ. Synthetic and therapeutic perspectives of nitrogen containing heterocycles as anti-convulsants. Bioorg Med Chem. 2020;28(15):115585. [DOI:10.1016/j.bmc.2020.115585] [PMID]
26. Ahmad S, Alam MZ, Salma U, Mohasin M, Rahaman PF, Parveen H, et al. A review on recent progress in synthesis and biological activities of thiadiazole and its derivatives. J Mol Str. 2024;1312:138438. [DOI:10.1016/j.molstruc.2024.138438]
27. Mahdi GA, Dakhel ZA. Synthesis, Characterization and Preliminary Pharmacological Evaluation of New Naproxen Containing 1, 3, 4-thiadiazole-2-thiol Derivatives. Iraqi J Pharm Sci. 2024;33(4SI):349-61. [DOI:10.31351/vol33iss(4SI)pp349-361]
28. Koval A, Lozynskyi A, Lesyk R. An overview on 1, 2, 4-triazole and 1, 3, 4-thiadiazole derivatives as potential anesthesic and anti-inflammatory agents. Pharm Sci. 2022;2 (36):10-7. [DOI:10.15587/2519-4852.2022.255276]
29. Amir M, Kumar H, Javed SA. Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen. Bioorg Med Chem Lett. 2007;17(16):4504-8. [DOI:10.1016/j.bmcl.2007.06.003] [PMID]
30. Gondru R, Kanugala S, Raj S, Ganesh Kumar C, Pasupuleti M, Banothu J, et al. 1,2,3-triazole-thiazole hybrids: Synthesis, in vitro antimicrobial activity and antibiofilm studies. Bioorg Med Chem Lett. 2021;33:127746. [DOI:10.1016/j.bmcl.2020.127746] [PMID]
31. Sarigol D, Uzgoren-Baran A, Tel BC, Somuncuoglu EI, Kazkayasi I, Ozadali-Sari K, et al. Novel thiazolo [3, 2-b]-1, 2, 4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies. Bioorg Med Chem. 2015;23(10):2518-28. [DOI:10.1016/j.bmc.2015.03.049] [PMID]
32. Apaydın S, Török M. Sulfonamide derivatives as multi-target agents for complex diseases. Bioorg Med Chem Lett. 2019;29(16):2042-50. [DOI:10.1016/j.bmcl.2019.06.041] [PMID]
33. Perazella MA, Herlitz LC. The Crystalline Nephropathies. Kidney Int Rep. 2021;6(12):2942-57. [DOI:10.1016/j.ekir.2021.09.003] [PMID] [PMCID]
34. Landquist J. Application as Pharmaceuticals. In: Katritzky A, Rees C, editors. Comprehensive Heterocyclic Chemistry: Pergamon; 1984. [DOI:10.1016/B978-008096519-2.00006-0]
35. Ottosen CF, Bjerg PL, Kümmel S, Richnow HH, Middeldorp P, Draborg H, et al. Natural attenuation of sulfonamides and metabolites in contaminated groundwater-Review, advantages and challenges of current documentation techniques. Water Res. 2024;254:121416. [DOI:10.1016/j.watres.2024.121416] [PMID]
36. Nasser NH, Hammud NH, Hasan SA, Abdalsadh AH, kareem Hussein A. Design and Synthesis of new Naproxen Analogues as Potential Anti-inflammatory Agents. Al Mustansiriyah J Pharm Sci. 2017;17(1):9-. [DOI:10.32947/ajps.v17i1.61]
37. Naser N, Hammud N, Hasan S, Abdalsadh H, Hussein A. Design and Synthesis of new Naproxen Analogues as Potential Anti- inflammatory Agents. Al Musta J Pharm Sci. 2017;17:42-9. [DOI:10.32947/ajps.v17i1.61]
38. Rollas S, Kucukguzel SG. Hydrazone, amide, carbamate, macromolecular and other prodrugs of doxorubicin. Open Drug Deliv J. 2008;2:77-85. [DOI:10.2174/1874126600802010077]
39. Naser AS. Design, synthesis and anti-inflammatory evaluation of new 2-amino heterocyclic derivatives of Naproxen. Univ Baghdad. 2017;9(8):38-4.
40. Luckose F, Pandey MC, Radhakrishna K. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-807. [DOI:10.1080/10408398.2012.708368] [PMID]
41. Jeannotte R. METABOLIC PATHWAYS | Nitrogen Metabolism. In: Batt C, Tortorello M, editors. Encyclopedia of Food Microbiology. Second ed: Academic Press; 2014. p. 544-60. [DOI:10.1016/B978-0-12-384730-0.00199-3]
42. Ferreira RMB, Teixeira ARN. AMINO ACIDS | Metabolism. In: Caballero B, editor. Encyclopedia of Food Sciences and Nutrition. Second ed: Academic Press; 2003. [DOI:10.1016/B0-12-227055-X/00040-7] [PMID]
43. Elhenawy AA, Al-Harbi LM, Moustafa GO, El-Gazzar MA, Abdel-Rahman RF, Salim AE. Synthesis, comparative docking, and pharmacological activity of naproxen amino acid derivatives as possible anti-inflammatory and analgesic agents. Drug Des Devel Ther. 2019;13:1773-90. [DOI:10.2147/DDDT.S196276] [PMID] [PMCID]
44. Naveen Kumar HS, Parumasivam T, Jumaat F, Ibrahim P, Asmawi MZ, Sadikun A. Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents. Med Chem Res. 2014;23(1):269-79. [DOI:10.1007/s00044-013-0632-2]
45. Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51(5):1409-16. [DOI:10.1093/jnci/51.5.1409] [PMID]
46. Tok TT, ÖZaŞIk Ö, SarigÖL D, Baran AU. Synthesis and molecular modeling studies of naproxen-based acyl hydrazone derivatives. Turk J Chem. 2015;39(1):54-83. [DOI:10.3906/kim-1401-91]
47. Abbas AH, Elias AN, Fadhil AA. Synthesis, characterization and biological evaluation of new potentially active hydrazones of naproxen hydrazide. Der Pharma Chemica. 2015;7(10):93-101.
48. Azizian H, Mousavi Z, Faraji H, Tajik M, Bagherzadeh K, Bayat P, et al. Arylhydrazone derivatives of naproxen as new analgesic and anti-inflammatory agents: Design, synthesis and molecular docking studies. J Mol Graph Model. 2016;67:127-36. [DOI:10.1016/j.jmgm.2016.05.009] [PMID]
49. Nakka M, Begum M, Varaprasad B, Reddy L, Bhattacharya A, Helliwell M, et al. Naproxen and ibuprofen based acyl hydrazone derivatives: Synthesis, structure analysis and cytotoxicity studies. J Chem Pharm Res Pharm Res. 2010;2:393-409.
50. Yang W, Feng Q, Peng Z, Wang G. An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking. Eur J Med Chem. 2022;234:114273. [DOI:10.1016/j.ejmech.2022.114273] [PMID]
51. Wang G, Wang Y, Fan S, Qiao C, Hao L, Yang H. Elevated-temperature corrosion inhibition of mild steel in sulfuric acid by coupled effects of imidazoline-type inhibitor and thiourea derivatives. J Mater Sci Technol. 2025(240):233-49. [DOI:10.1016/j.jmst.2025.05.004]
52. Abd Halim AN, Ngaini Z. Review on the synthesis of thiourea-triazine hybrid derivatives and its applications primarily in biological context. Phosphorus Sulfur Silicon Relat Elem. 2025;200(2):109-32. [DOI:10.1080/10426507.2025.2457458]
53. Nedeljković N, Nikolić M, Čanović P, Zarić M, Živković Zarić R, Bošković J, et al. Synthesis, characterization, and investigation of anti-inflammatory and cytotoxic activities of novel thiourea derivatives of naproxen. Pharmaceutics. 2023;16(1):1. [DOI:10.3390/pharmaceutics16010001] [PMID] [PMCID]
54. Schlecht S, Gunderson E, Fowler R, Aguilar T. Micro Volume Purification of His-Tagged Proteins with IMAC Ni-Charged Resin. 2024. (Online Access on Oct. 20, 2025). Available from: [DOI:10.17504/protocols.io.3byl49yejgo5/v1]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
